Loading viewer...
investor_presentation
Format: PDF investor_presentation
Veeco (Nasdaq: VECO) February 11, 2021Q4 2020 Financial Results Conference Call
Veeco (Nasdaq: VECO)
February 11, 2021Q4 2020
Conference CallQ4 2020 Financial Results Conference Call | All Rights Reserved. ©2021
2This presentation contains “forward -looking statements”, within the meaning of the safe harbor provisions of the U.S. Private
Securities Litigation Reform Act of 1995, as amended, that are based on management’s expectations, estimates, projections and
assumptions. Words such as “expects,” “anticipates,” “plans,” “believes,” “scheduled,” “estimates” and variations of these wo rds
and similar expressions are intended to identify forward -looking statements. Forward -looking statements include, but are not
limited to, those regarding anticipated growth and trends in our businesses and markets, industry outlooks and demand drivers ,
our investment and growth strategies, our development of new products and technologies, our business outlook for current and
future periods, the impact of the COVID -19 pandemic, our ongoing transformation initiative and the effects thereof on our
operations and financial results; and other statements that are not historical facts. These statements and their underlying
assumptions are subject to risks and uncertainties and are not guarantees of future performance. Factors that could cause act ual
results to differ materially from those expressed or implied by such statements include, without limitation: the level of dem andfor
our products; global economic and industry conditions; the effects of regional or global health epidemics, including the effe ctsof
the COVID -19 pandemic on the Company’s operations and on those of our customers and suppliers; global trade issues, including
the ongoing trade disputes between the U.S. and China, and changes in trade and export license policies; our dependency on
third -party suppliers and outsourcing partners; the timing of customer orders; our ability to develop, deliver and support new
products and technologies; our ability to expand our current markets, increase market share and develop new markets; the
concentrated nature of our customer base; our ability to obtain and protect intellectual property rights in key technologies; our
ability to achieve the objectives of operational and strategic initiatives and attract, motivate and retain key employees; th e
variability of results among products and end -markets, and our ability to accurately forecast future results, market conditions, and
customer requirements; the impact of our indebtedness, including our convertible senior notes and our capped call transaction s;
and other risks and uncertainties described in our SEC filings on Forms 10 -K, 10 -Q and 8 -K, and from time -to-time in our other S EC
reports. All forward -looking statements speak only to management’s expectations, estimates, projections and assumptions as of
the date of this presentation. The Company does not undertake any obligation to update or publicly revise any forward -looking
Preview truncated — download the full document for the complete content.
investor_presentation
30 Pages
investor_presentation
28 Pages
Acasti Pharma
Cabot Microelectronics Investor Presentation — May 2021
investor_presentationinvestor_presentation
16 Pages
Cabot Microelectronics Corporation
Meghmani Finechem Corporate Presentation
investor_presentationinvestor_presentation
24 Pages
Meghmani Finechem Limited